Moreover, the inhibition on the sensitivity of NSCLC to cisplatin was recovered through miR-4458 inhibition or REV3L upregulation by silencing circRNA PRMT5 (Pang et al., 2020). Here, PRMT5 is linked to non-small cell lung carcinoma.